The administration of hAGP (from day 0 (before IR) to day 7) to AGP KO (IR) mice significantly suppressed the extent of renal fibrosis that was observed in the AGP KO (IR) mice (Fig. 4A–D). The gene discussed is ATP5MK; the disease is renal fibrosis.